Caspase Cleavage of HER-2 Releases a Bad-like Cell Death Effector
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (26) , 18269-18282
- https://doi.org/10.1074/jbc.m802156200
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 ExpressionClinical Cancer Research, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Specific Cleavage of Mcl-1 by Caspase-3 in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Jurkat Leukemia T CellsJournal of Biological Chemistry, 2005
- Proteolysis of the Mismatch Repair Protein MLH1 by Caspase-3 Promotes DNA Damage-induced ApoptosisPublished by Elsevier ,2004
- Caspase-8-Dependent HER-2 Cleavage in Response to Tumor Necrosis Factor α Stimulation Is Counteracted by Nuclear Factor κB through c-FLIP-L ExpressionCancer Research, 2004
- Caspase Proteolysis of the Cohesin Component RAD21 Promotes ApoptosisPublished by Elsevier ,2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997
- Epstein–Barr Virus EBNA-2 Gene Expression Enhances Lymphotoxin Production by B LymphocytesMethods, 1997
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987